<?xml version="1.0" encoding="UTF-8"?>
<ref id="B154-jcm-09-02084">
 <label>154.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dastan</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Nadji</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Saffaei</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Marjani</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Moniri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jamaati</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hashemian</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Baghaei</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Abedini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Varahram</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Subcutaneous Administration of Interferon Beta-1a for COVID-19: A Non-Controlled Prospective Trial</article-title>
  <source>Int. Immunopharmacol.</source>
  <year>2020</year>
  <volume>85</volume>
  <fpage>106688</fpage>
  <pub-id pub-id-type="doi">10.1016/j.intimp.2020.106688</pub-id>
  <pub-id pub-id-type="pmid">32544867</pub-id>
 </element-citation>
</ref>
